Third Quarter 2024 Financial Results Total revenue for the third quarter of 2024 was $2.0 million, an increase of 34% compared to the prior year period. Sepsis test revenue grew 34% compared to the ...
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated ...
12, 2024 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical ... which drew widespread attention for its robust performance as a powerful solution for diverse ...
Objective To determine the association between survey-based self-reported problematic low energy availability indicators (LEA-I) and race performance and intra-event medical encounters ... of male ...
Bruker Corporation today announced a major technological breakthrough in the CellScapetm Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF). Launched in 2022, the ...
In China, where nursing education faces challenges such as unequal resource distribution, limited access to clinical training, and scalability issues, artificial intelligence (AI) has emerged as a ...